Evidence map›Paper›PMID 32466461›Full record

ArticleCells2020

Anti-Inflammatory Performance of Lactose-Modified Chitosan and Hyaluronic Acid Mixtures in an In Vitro Macrophage-Mediated Inflammation Osteoarthritis Model.

Elena Tarricone, Elena Mattiuzzo, Elisa Belluzzi, Rossella Elia, Andrea Benetti, Rina Venerando, Vincenzo Vindigni, Pietro Ruggieri, Paola Brun

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Elena TarriconeDepartment of Molecular Medicine, Histology Unit, University of Padova, 35121 Padova, Italy.
Elena MattiuzzoDepartment of Molecular Medicine, Histology Unit, University of Padova, 35121 Padova, Italy.
Elisa BelluzziMusculoskeletal Pathology and Oncology Laboratory, Orthopedic Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, 35128 Padova, Italy.ORCID 0000-0003-1129-2574
Rossella EliaDepartment of Molecular Medicine, Histology Unit, University of Padova, 35121 Padova, Italy.
Andrea BenettiDepartment of Molecular Medicine, Histology Unit, University of Padova, 35121 Padova, Italy.
Rina VenerandoDepartment of Molecular Medicine, University of Padova, 35121 Padova, Italy.
Vincenzo VindigniClinic of Plastic and Reconstructive Surgery, University of Padova, 35128 Padova, Italy.
Pietro RuggieriOrthopedic Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, 35128 Padova, Italy.ORCID 0000-0001-9617-9882
Paola BrunDepartment of Molecular Medicine, Histology Unit, University of Padova, 35121 Padova, Italy.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development and progression of osteoarthritis (OA) is associated with macrophage-mediated inflammation that generates a broad spectrum of cytokines and reactive oxygen species (ROS). This study investigates the effects of mid-MW hyaluronic acid (HA) in combination with a lactose-modified chitosan (CTL), on pro-inflammatory molecules and metalloproteinases (MMPs) expression, using an in vitro model of macrophage-mediated inflammation.

methodsTo assess chondrocyte response to HA and CTL in the presence of macrophage derived inflammatory mediators, cells were exposed to the conditioned medium (CM) of U937 activated monocytes and changes in cell viability, pro-inflammatory mediators and MMPs expression or ROS generation were analysed.

resultsCTL induced changes in chondrocyte viability that are reduced by the presence of HA. The CM of activated U937 monocytes (macrophages) significantly increased gene expression of pro-inflammatory molecules and MMPs and intracellular ROS generation in human chondrocyte cultures. HA, CTL and their combinations counteracted the oxidative damage and restored gene transcription for IL-1β, TNF-α, Gal-1, MMP-3 and MMP-13 to near baseline values.

conclusionsThis study suggests that HA-CTL mixture attenuated macrophage-induced inflammation, inhibited MMPs expression and exhibited anti-oxidative effects. This evidence provides an initial step toward the development of an early stage OA therapeutic treatment.

Indexed as

Models, BiologicalAntigens, CDAntigens, Differentiation, MyelomonocyticAnti-Inflammatory AgentsCD68 MoleculeCell SurvivalChitosanChondrocytesCulture Media, ConditionedDown-RegulationGene Expression RegulationHumansHyaluronic AcidInflammationInflammation MediatorsInterleukin-1betaAntigens, CDAntigens, Differentiation, MyelomonocyticAnti-Inflammatory AgentsCD68 antigen, humanCD68 MoleculeChitosanCulture Media, ConditionedHyaluronic AcidIL1B protein, humanInflammation MediatorsInterleukin-1betaLactoseMatrix MetalloproteinasesReactive Oxygen Specieschitosanchondrocytehyaluronic acidinflammationosteoarthritis

Identifiers

PMID32466461
PMCPMC7349682
OpenAlexW3031433013

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.